JPH11506792A - 皮膚疾患治療のためのビタミンd4誘導体の使用 - Google Patents
皮膚疾患治療のためのビタミンd4誘導体の使用Info
- Publication number
- JPH11506792A JPH11506792A JP9501598A JP50159897A JPH11506792A JP H11506792 A JPH11506792 A JP H11506792A JP 9501598 A JP9501598 A JP 9501598A JP 50159897 A JP50159897 A JP 50159897A JP H11506792 A JPH11506792 A JP H11506792A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- compound
- formula
- dihydroxyvitamin
- solvates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記式(I)の化合物の有効量でヒト皮膚癌細胞を処置することを含むヒト 皮膚癌細胞の過剰増殖活性を抑制する方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 2.下記式(I)の化合物の治療的有効量を皮膚疾患を罹患する患者に投与する ことを含む皮膚疾患の治療方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 3.下記式(I)の化合物の治療的有効量を皮膚炎を罹患する患者に投与するこ とを含む皮膚炎の治療方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 4.下記式(I)の化合物の治療的有効量を乾癬を罹患する患者に投与すること を含む乾癬の治療方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 5.下記式(I)の化合物の治療的有効量をヒトに投与することを含む、ヒト皮 膚癌の細胞増殖作用、乾癬、湿疹、皮膚の水分過剰および皮脂分泌を軽減させる ためにヒトを処置する方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 6.下記式(I)の化合物の有効量をヒトに投与することを含むある効果を患者 で達成する方法であって、当該効果が皮膚癌、乾癬、湿疹、皮膚の水分過剰また は皮脂分泌の治療であり、当該量が細胞の増殖活性を抑制させるために十分で、 それによって当該効果を達成する前記ある効果を達成する方法。 (式中、R1はHまたはOHのいずれかで、R2はHまたはOHのいずれか並び にその塩、水和物および溶媒和物である。) 7.式(I)の化合物が1α,24−ジヒドロキシビタミンD4である請求の範 囲第1、2、3、4、5または6項のいずれかに記載の方法。 8.式(I)の化合物が1α,24(R)−ジヒドロキシビタミンD4で、その (S)型を実質的に含まない請求の範囲第1、2、3、4、5または6項のいず れかに記載の方法。 9.当該量が局所的に投与される請求の範囲第1、2、3、4、5または6項の いずれかに記載の方法。 10.さらに当該投与段階が、レチノイド、クロマノール、β作動薬、抗炎症剤、 角質形成剤およびその組み合わせから成る群から選ばれる第二の薬剤を投与する ことを含む請求の範囲第9項の方法。 11.当該量が経口的に投与される請求の範囲第1、2、3、4、5または6項の いずれかに記載の方法。 12.当該量が非経口的に投与される請求の範囲第1、2、3、4、5または6項 のいずれかに記載の方法。 13.当該組成物が、医薬的に許容できる担体中に1α,24−ジヒドロキシビタ ミンD4の(R)立体異性を含み、その(S)型異性体を含まない改良された 治療用組成物。 14.当該組成物が局所組成物であって、さらに当該1α,24−ジヒドロキシビ タミンD4が約1μgから100μg/グラム組成物の濃度で含まれる請求の範 囲第13項の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,342 | 1995-06-07 | ||
US08/484,342 US5763428A (en) | 1990-09-21 | 1995-06-07 | Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof |
PCT/US1996/009222 WO1996040154A1 (en) | 1995-06-07 | 1996-06-06 | Use of vitamin d4 derivatives for treating skin disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11506792A true JPH11506792A (ja) | 1999-06-15 |
Family
ID=23923757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9501598A Ceased JPH11506792A (ja) | 1995-06-07 | 1996-06-06 | 皮膚疾患治療のためのビタミンd4誘導体の使用 |
Country Status (9)
Country | Link |
---|---|
US (1) | US5763428A (ja) |
EP (1) | EP0831838B1 (ja) |
JP (1) | JPH11506792A (ja) |
AT (1) | ATE258796T1 (ja) |
AU (1) | AU6256996A (ja) |
CA (1) | CA2222591A1 (ja) |
DE (1) | DE69631478T2 (ja) |
PL (1) | PL323798A1 (ja) |
WO (1) | WO1996040154A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013075924A (ja) * | 2000-10-27 | 2013-04-25 | Leo Pharma As | 少なくとも1つのビタミンdまたは1つのビタミンdアナログおよび少なくとも1つのコルチコステロイドを含有する局所用組成物 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US6166000A (en) * | 1991-01-08 | 2000-12-26 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2 |
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
AU762481C (en) * | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6552009B2 (en) | 1998-07-16 | 2003-04-22 | Gentrix Llc | Compositions and methods of treating abnormal cell proliferation |
US20010002396A1 (en) * | 1998-07-16 | 2001-05-31 | Charles Achkar | Compositions and methods of treating skin conditions |
IL153378A0 (en) * | 2000-07-18 | 2003-07-06 | Bone Care Internat Inc | STABILIZED 1alpha-HYDROXY VITAMIN D |
WO2003047595A1 (en) * | 2001-12-03 | 2003-06-12 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin d compounds |
US20030143165A1 (en) * | 2002-01-25 | 2003-07-31 | Allan Evans | NSAID-containing topical formulations that demonstrate chemopreventive activity |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR877356A (fr) * | 1940-12-03 | 1942-12-04 | Eberspaecher J | Dispositif utilisable à bord des avions pour le chauffage, l'atténuation des flammes et l'utilisation de la réaction |
US2383446A (en) * | 1941-06-04 | 1945-08-28 | Du Pont | Antirachitic materials and processes for their production |
US3697559A (en) * | 1971-02-25 | 1972-10-10 | Wisconsin Alumni Res Found | 1,25-dihydroxycholecalciferol |
US3741996A (en) * | 1971-12-02 | 1973-06-26 | Wisconsin Alumni Res Found | 1{60 -hydroxycholecalciferol |
US4202829A (en) * | 1978-01-05 | 1980-05-13 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4195027A (en) * | 1978-01-16 | 1980-03-25 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4260549A (en) * | 1979-05-21 | 1981-04-07 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4362710A (en) * | 1980-07-04 | 1982-12-07 | Nissan Gosei Kogyo Co., Ltd. | Feeds for baby pigs, process for preparing the same and method of breeding baby pigs |
US4689180A (en) * | 1984-01-30 | 1987-08-25 | Wisconsin Alumni Research Foundation | 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound |
US4555364A (en) * | 1984-11-01 | 1985-11-26 | Wisconsin Alumni Research Foundation | Method for preparing 1-hydroxyvitamin D compounds |
US4728643A (en) * | 1984-11-02 | 1988-03-01 | The General Hospital Corporation | Method of treating psoriasis |
US4661294A (en) * | 1985-03-18 | 1987-04-28 | The General Hospital Corporation | Biologically active 1-thio derivatives of vitamin D |
WO1987000834A1 (en) * | 1985-08-02 | 1987-02-12 | Leo Pharmaceutical Products Ltd. A/S | Novel vitamin d analogues |
JP2550391B2 (ja) * | 1988-06-30 | 1996-11-06 | 日清製粉株式会社 | 1β−ヒドロキシビタミンD▲下2▼およびD▲下3▼の製造方法 |
CA1333616C (en) * | 1989-03-09 | 1994-12-20 | Hector F. Deluca | 19-nor-vitamin d compounds |
JP2645130B2 (ja) * | 1989-03-31 | 1997-08-25 | 日清製粉株式会社 | ステロイド誘導体 |
US5185150A (en) * | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
WO1992005130A1 (en) * | 1990-09-21 | 1992-04-02 | Lunar Corporation | NOVEL 1α-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES |
EP0562497A1 (en) * | 1992-03-27 | 1993-09-29 | Nisshin Flour Milling Co., Ltd. | 1 alpha-hydroxy vitamins D7 and D4' processes for the preparation thereof and pharmaceutical compositions |
-
1995
- 1995-06-07 US US08/484,342 patent/US5763428A/en not_active Expired - Lifetime
-
1996
- 1996-06-06 EP EP96921322A patent/EP0831838B1/en not_active Expired - Lifetime
- 1996-06-06 AT AT96921322T patent/ATE258796T1/de not_active IP Right Cessation
- 1996-06-06 DE DE69631478T patent/DE69631478T2/de not_active Expired - Fee Related
- 1996-06-06 AU AU62569/96A patent/AU6256996A/en not_active Abandoned
- 1996-06-06 PL PL96323798A patent/PL323798A1/xx unknown
- 1996-06-06 CA CA002222591A patent/CA2222591A1/en not_active Abandoned
- 1996-06-06 WO PCT/US1996/009222 patent/WO1996040154A1/en active IP Right Grant
- 1996-06-06 JP JP9501598A patent/JPH11506792A/ja not_active Ceased
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013075924A (ja) * | 2000-10-27 | 2013-04-25 | Leo Pharma As | 少なくとも1つのビタミンdまたは1つのビタミンdアナログおよび少なくとも1つのコルチコステロイドを含有する局所用組成物 |
Also Published As
Publication number | Publication date |
---|---|
DE69631478T2 (de) | 2004-11-25 |
EP0831838B1 (en) | 2004-02-04 |
CA2222591A1 (en) | 1996-12-19 |
ATE258796T1 (de) | 2004-02-15 |
EP0831838A1 (en) | 1998-04-01 |
MX9709684A (es) | 1998-06-28 |
US5763428A (en) | 1998-06-09 |
AU6256996A (en) | 1996-12-30 |
DE69631478D1 (de) | 2004-03-11 |
WO1996040154A1 (en) | 1996-12-19 |
PL323798A1 (en) | 1998-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11506792A (ja) | 皮膚疾患治療のためのビタミンd4誘導体の使用 | |
KR100231809B1 (ko) | 1알파-하이드록시 비타민 d4 및 이의 중간체 및 동족체, 및 이를 포함하는 약제학적 조성물 | |
DE69911596T2 (de) | 24-hydroxy vitamin d, deren analogen und verwendungen | |
US5798345A (en) | Method of inhibiting the hyperproliferation of malignant cells | |
EP0550702B1 (en) | METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2? | |
US5786348A (en) | Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2 | |
CA2121689C (en) | 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use | |
US20020032179A1 (en) | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 | |
AU2002315463A1 (en) | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 | |
US5801164A (en) | Methods of treating osteoporosis prophylactically or therapeutically | |
US20040009958A1 (en) | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 | |
US6166000A (en) | Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2 | |
US6251883B1 (en) | Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2 | |
MXPA97009684A (en) | Use of vitamin d4 derivatives for treatment of p disorders | |
MXPA97009683A (en) | Use of vitamin d4 derivatives for treatment against the can | |
AU6301699A (en) | Methods for preparing and use of 1alpha,24(S)-dihydroxy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060711 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060718 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060705 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20061204 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070123 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070105 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070220 |